Www.ecas-heartrhythm.org



ECAS 2019 ADVANCE SCIENTIFIC PROGRAMSUNDAY JUNE 16, 20198:30 AM - 10:00 AMROOM GRAND LARGEWorkshop WS-01Atrial fibrillation ablation in 2020Chairpersons: Douglas Packer (Rochester, USA), Mahmoud Suleiman (Ha?fa, IL)Is there a mortality benefit with AF ablation in CABANA?: Impact of normal sinus rhythmDouglas Packer (Rochester, USA)Dealing with CHF with AF?: Biventricular pacing or AF ablation Hugh Calkins (Baltimore, USA) Revisiting mode of AF ablation?: linear and rotor ablationDavid Wilber (Chicago, USA)AF ablation – endpoint of AF ablation?: 30 sec vs monitoringJeanne Poole (Seattle, USA)SUNDAY JUNE 16, 20198:30 AM - 10:00 AMROOM ESTAQUEWorkshop WS-02Prevention and management of device infectionsChairpersons: Bruce Wilkoff (Cleveland, USA), Christoph Starck (Berlin, DE) Pathophysiology and bacteriology of CIED infectionsRizwan M Sohail (Rochester, USA)Impact of CIED Infections on survivalBruce Wilkoff (Cleveland, USA)Prophylactic and peri procedural antibiotics before and after the PADIT trialJamil Bashir (Vancouver, CA)Antibiotic envelope therapy before and after WRAP-IT Charles Kennergren (Gothenburg, Sweden)Panel discussion: What is and should be the rate of CIED Infection and what are the barriers to optimal infection prevention?SUNDAY JUNE 16, 20198:30 AM - 10:00 AMROOM JOLIETTEWorkshop WS-03ECG pacemaker and CRT dysfunction (case studies)Chairpersons: Eli Ovsyshcher (Beersheba, IL)Bengt Herweg (Tampa, USA)Promund Obel (Johannesburg, ZA)Pugazhendhi Vijayaraman (Wilkes Barre, USA)Brian Olshansky (Iowa City, USA)SUNDAY JUNE 16, 20198:30 AM - 10:00 AM ROOM SAINT JEANWorkshop WS-04A mandatory issue: anatomical knowledge for catheter ablation targetsChairpersons: Roger Winkle (Palo Alto, USA), Mohammad Shenasa (San Jose, USA)AVNRT and accessory pathway ablationCarlo Lavalle (Rome, IT)Atrial flutter ablation John Catanzaro (Jacksonville, USA)Atrial fibrillation ablationLuigi Di Biase (New York, USA)Ventricular Tachycardia ablationRichard Schilling (London, GB)SUNDAY JUNE 16, 20198:30 AM - 10:00 AMROOM MUCEMWorkshop WS-05Syncope and tachycardias related to autonomous nervous system disturbances Chairpersons: David Benditt (Minneapolis, USA), Richard Sutton (Monaco, MC)Postural orthostatic tachycardia syndrome (POTS)David Benditt (Minneapolis, USA)Effect of AF on the autonomous nervous system and cognitive impairmentLena Rivard (Montreal, CA) Syncope in competitive athletesAntonio Raviele (Venice, IT) NOT COMINGInappropriate sinus tachycardia: a diagnosis of eliminationSamuel Levy (Marseille, FR)SUNDAY JUNE 16, 20198:30 AM - 10:00 AMROOM NOTRE DAMEWorkshop WS-06Case-based presentation of EP tracings dedicated to young electrophysiologistsChairpersons: Roberto De Ponti (Varese, IT), Albert Waldo (Cleveland, USA)Various clinical aspects of atrial flutter Albert Waldo (Cleveland, USA)Tracings of arrhythmias involving the atrioventricular junction Jacopo Marazzato (Varese, IT)Tracings of arrhythmias involving atrioventricular accessory pathwaysWarren Jackman (Oklahoma City, USA)Tracings of ventricular arrhythmias Roland Tilz (Luebeck, DE)Sunday JUNE 16, 2019 12:15 pm-1:45 pm Room EUGENIELuncheon PanelSUNDAY JUNE 16, 2019 2:00 PM - 3:30 PMROOM GRAND LARGESession SP-0112th　Japan HRS-ECAS (DRAFT)Program coordinators: Samuel Levy (ECAS) and Yuji Nakazato (JHRS) Cardiac arrhythmia ablation: Learning from difficult casesChairpersons: Kenzo Hirao (Tokyo, JP), Yuji Nakazato (Tokyo, JP)Atypical flutter ablationDipen Shah (Geneva, CH）2. Atrial fibrillation ablationKazuhiro Satomi （Tokyo, JP） 3. PVC ablation Joel Fedida (Paris, FR) 4. VT/VF ablationAkihiko Nogami (Tsukuba, JP) SUNDAY JUNE 16, 20192:00 PM - 3:30 PMROOM ESTAQUESession AF-01New insights into mechanisms and pathogenesis of atrial fibrillation (AF)Chairpersons : Albert Waldo (Cleveland, USA), Reza Wakili (Essen, DE)Fat and AF Stephane Hatem (Paris, FR) Obstructive sleep apnea and AF ablationMahmoud Suleiman (Ha?fa, IL)Ventricular fibrosis and AF Fu Siong Ng (London, GB)Inflammatory signaling and AF Dobromir Dobrev, (Essen, DE)SUNDAY JUNE 16, 20192:00 PM - 3:30 PMROOM JOLIETTESession SP-02Aggressive ablation for ventricular tachycardia?Chairpersons: Richard Schilling (London, GB), Douglas Packer (Rochester, USA)Best ablative guides for ARVC, sarcoid, myocarditis, and other offbeat ventricular tachycardiasDavid Wilber (Chicago, USA)Role of intracardiac ultrasound in guided VT ablation: from PVCs to ICE-guided structural interventionsJared Thomas Bench (Philadelphia, USA)Recent Clinical outcomes of advanced VT ablation: “Photon vs. particle therapy”?Phillip S. Cuculich (Saint Louis, USA) Potential effect of VT ablation on mortalityKarl-Heinz Kuck (Hamburg, DE)SUNDAY JUNE 16, 20192:00 PM - 3:30 PM ROOM SAINT JEANSession SP-03Cardiovascular complications of energy drinksChairpersons: Samuel Levy (Marseille, FR), Antonio Raviele (Venice, IT)Composition of commercially available energy drinksLuca Santini (Rome, IT)Reports of cardiovascular complications of energy drinksAli Oto (Ankara, TR)Role of caffeine and other ingredients contained in energy drinksAlessandro Capucci (Ancona, IT)ECAS recommendation statement Maurizio Santomauro and Carla Riganti (Naples, IT)SUNDAY JUNE 16, 20192:00 PM - 3:30 PMROOM MUCEMSession SP-04Septal accessory pathways: diagnosis, localization and catheter ablation(Interactive case discussions)Session proposed and conducted by Jasbir Sra (Milwaukee, USA), Warren Jackman (Milwaukee and Oklahoma City, USA) and Stavros Stavrakis (Oklahoma City, USA) Anteroseptal pathway-interactive case discussionLeft vs right mid septal pathway-interactive case discussionPostero-septal vs accessory pathway from the middle cardiac vein: interactive case discussionDiscussion with audience participationSUNDAY JUNE 16, 20192:00 PM - 3:30 PMROOM NOTRE DAMESession SP-05Management of lead extraction patientsChairpersons: Charles Kennergren (Gothenburg, SE), Eli Ovsyshcher (Beersheba, IL)Preoperative imaging for transvenous lead extractionDonald Hegland (Durham, USA)Intraoperative imaging for transvenous lead extractionHemal Nayak (Chicago, USA)Prepping and protection during vascular emergencies Bruce Wilkoff (Cleveland, USA)Surgical rescue for SVC and other vascular emergencies Jamil Bashir (Vancouver, CA)3:30 PM - 4:00 PM Coffee break and visit to postersSUNDAY JUNE 16, 2019 4:00 PM - 5:30 PMROOM GRAND LARGESession SP-06Anticoagulation using DOACs in atrial fibrillation: what is new ?Supported by an educational grant from Bayer AGChairs: Thomas Deering (Atlanta, USA), Christine Albert (Boston, USA)CardioversionEugene Crystal (Toronto, CA)AF AblationLuigi Di Biase (New-York, USA)Direct oral anticoagulants in patients with renal impairment Hendrik Bonnemeier (Kiel, DE)Advances and limitations in the real wordThomas Deering (Atlanta, USA) AF DOAC?ControversiesAndrea Russo?(Camden, USA)SUNDAY JUNE 16, 2019 4:00 PM - 5:30 PMROOM ESTAQUESession AF-02Trials and meta-analyses in atrial fibrillation and their impact on current practiceChairpersons: Riccardo Cappato (Milan, IT), Antony Chu (Providence, USA)Interpretation of the CABANA Trial resultsDouglas L Packer (Rochester, USA)Interpretation of the CASTLE Trial results Johannes Brachmann (Coburg, DE)Targeting ganglion plexi in AF ablation with and without PV isolationSunny Po (Oklahoma City, USA) Targeting complex electrograms with and without PV isolation Julien Seitz (Marseille, FR)SUNDAY JUNE 16, 20194:00 PM - 5:30 PMROOM JOLIETTESession SD-01How to optimize pulmonary vein isolation?Chairpersons: Ellen Hoffmann (Munich, DE), David Haines (Royal Oak, USA)20 years of pulmonary vein isolation – Contemporary outcomesKenzo Hirao (Tokyo, JP) Strategies to optimize PVI using radiofrequency energyDavid Haines (Royal Oak, USA)Strategies to optimize PVI using cryoablationFlorian Straube (Munich, DE)Role of contact forceRoberto De Ponti (Varese, IT)Additional sites beyond the pulmonary veinsLi-Wei Lo (Taipei, TW)SUNDAY JUNE 16, 20194:00 PM - 5:30 PM ROOM SAINT JEANSession SP-07ECG interpretation course (Part 1: conduction disturbances)A tribute to Agustin Castellanos Jr (1927-2017)Chairpersons: Sanjeev Saksena (Warren, USA), Mark Estes III (Boston, USA)The Bayes syndrome Antoni Bayes de Luna (Barcelona, ES)What is new in congenital AV block management? George van Hare (St Louis, USA)Conduction abnormalities complicating acute myocardial infarctionSamuel Lévy (Marseille, FR) ECG of bradyarrhythmiasBengt Herweg (Tampa, USA)SUNDAY JUNE 16, 20194:00 PM - 5:30 PMROOM MUCEMSession SP-08Challenges in clinical care of patients with the dysautonomic syndromesChairpersons: David Benditt (Minneapolis, USA), David Cannom (Los Angeles, USA)Clinical characteristics that assure the diagnosis of POTS and misleading symptoms Brian Olshansky (Iowa, USA)Role of autoimmune disorders and mast cell diseases in dysautonomic syndromesDavid Benditt (Minneapolis, USA)Role of clinical laboratory testing for the differential diagnosis of dysautonomic syndromesGert van Dijk, (Leiden, NL)Impact of education and support in the care of patients with dysautonomic syndromes?Richard Sutton (Monaco, MC).SUNDAY JUNE 16, 20194:00 PM - 5:30 PMROOM NOTRE DAMESession SP-09Complications during electrophysiological proceduresChairpersons: Dipen Shah (Geneva, CH), Prapa Kanagaratnam (London, GB)Complications of catheter ablation of atrial fibrillation and flutter in GermanyGerhard Steinbeck (Munich, DE)Arrhythmic emergencyStephanie Fichtner (Munich, DE) Pericardial tamponadeNoel Boyle (Los Angeles, USA)Thermic esophagus damageThomas Deneke (Bad Neustadt, DE)My worst nightmareRichard Schilling (London, GB)Room EUGENIE5:30 PM to 6:00 PMPhilippe Coumel Special lecture: By Opening ceremonyOutstanding Achievement Awards Followed by a cocktail ReceptionMONDAY JUNE 17, 2019 8:30 AM - 10:00 AMROOM GRAND LARGESession SD-02Prevention of sudden cardiac death (SCD) in young adultsChairpersons: Mark N. Estes III (Pittsburgh, USA), Xavier Jouven (Paris, FR)Physiopathology of SCDMunther K. Homoud (Boston, USA) Risk stratification of SCD in young adults: Have we progressed?Domenico Corrado (Padua, IT)Sudden cardiac death during sports activitiesEloi Marijon (Paris, FR)Autopsy as a tool in the prevention of sudden death in the youngAudrey Farrugia-Jacamon (Strasbourg, FR) MONDAY JUNE 17, 20198:30 AM - 10:00 AMROOM ESTAQUESession AF-03Ablation for atrial fibrillation (AF): clinical challenges and new frontiers Chairpersons:? Luc Jordaens (Brussels, BE), Neil Sulke (Eastbourne, GB)Challenges in persistent AF ablation: Targets beyond the PVs Walid Saliba (Cleveland, USA)Treatment strategies post CABANA: Did we miss the real questions in AF care? Ayman Hussein (Cleveland, USA)Simultaneous LAA occlusion and atrial fibrillation ablation: is it a risk or a benefit? Lucas Boersma (Amsterdam, NL)Anticoagulation cessation after successful ablation: Should we do it? Antony Chu (New-York, USA) MONDAY JUNE 17, 20198:30 AM - 10:00 AM ROOM JOLIETTESession SP-10New guidelines in arrhythmia management: How should these change patient care?Chairpersons: John Camm (London, GB), Robert Hauser (Minneapolis, USA)Ventricular arrhythmia and sudden death prevention: Are we saving lives? Christine Albert (Boston, USA)Catheter and surgical ablation for AF: Where are we in 2018? Hugh Calkins (Baltimore, USA)Bradycardia and device management: How do the new guidelines Impact patient care? Massimo Santini (Rome, IT) Can patients with a non-MRI conditional device undergo a safe MRI? Julia Indik (Tucson, USA) MONDAY JUNE 17, 20198:30 AM - 10:00 AMROOM SAINT JEANSession WS-07 Risk of sudden cardiac death in the Brugada syndromeChairpersons: Dobromir Dobrev (Essen, DE), Bo G. Winkel (Copenhagen DK)Pathogenesis of the Brugada syndrome Bo G. Winkel (Copenhagen DK) Pharmacotherapy of Brugada syndromeLena Rivard (Montreal, CA)Indications of implantable cardioverter defibrillator in the Brugada SyndromeDaniel Steven (Cologne, DE) Debate: Catheter ablation plays a role in the Brugada syndrome (30min)Protagonist: Philippe Chevalier (Lyon, FR)Antagonist: Riccardo Cappato (Milan, IT)MONDAY JUNE 17, 20198:30 AM - 10:00 AMROOM MUCEMSession SP-11Stroke prevention in atrial fibrillation – State of the artChairpersons: Andrea Russo (Camden, USA), Ernst Vester (Düsseldorf, DE)Pharmacological stroke preventionHeidi Estner (Munich, DE)Endocardial LAA OcclusionThorsten Lewalter (Munich, DE)Epicardial LAA exclusionLuigi Di Biase (New-York, USA) Surgical LAA ClosureSacha Salzberg, (Zurich, CH)Monday JUNE 17, 2019 12:15PM to 1:45PMRoom EUGENIELuncheon PanelBayerMONDAY JUNE 17, 2019 2:00 PM - 3:30 PMROOM GRAND LARGESession SD-03First EURA-ECAS Special SessionSudden death in Hypertrophic Cardiomyopathy (HCM)Chairpersons: Christine Albert (Boston, USA), Yurij Karpenko (Odessa, Ukraine)Prevention of sudden cardiac death after septal myectomy in HCMMark Estes III (Pittsburgh, USA) ICD for primary prevention of sudden death in hypertrophic cardiomyopathy David Cannom (Los Angeles, USA)Value of electrophysiologic testing in HCMAndrey Ardashev (Moscow, RU) Prevention of stroke in patients with HCM and AFBrian Downey (Boston, USA) MONDAY JUNE 17, 20192:00 PM - 3:30 PMROOM ESTAQUESession AF-04Do we need antiarrhythmic drug therapy in the AF ablation era?Chairpersons: Nils Edvardsson (Goteborg, SE), Alessandro Capucci (Ancona, IT), Antiarrhythmic drugs for termination of recent onset atrial fibrillation Alessandro Capucci (Ancona, IT)Use of antiarrhythmic therapy before and after electrical cardioversionJuan Tamargo (Madrid, ES) Antiarrhythmic therapy for AF in heart failure with preserved ejection fraction (HFpEF) Samuel Lévy (Marseille, FR)Short-term use of antiarrhythmic drug therapy after catheter ablation (The East-AF Trial) Kasuaki Kaitani (Tenri, JP)MONDAY JUNE 17, 20192:00 PM - 3:30 PMROOM JOLIETTESession WS-09A tribute to Arthur Moss, MD In MemoriamICD therapy in 2019: Is it time to alter current device selection criteria Introduction: Arthur Moss, MD A giant in the “Fight against sudden death” (5min)David Cannom (Los Angeles, USA), Chairpersons: Massimo Santini (Rome, IT), David Cannom (Los Angeles, USA)LV ejection fraction: The legacy of an AVID substudy evolving to present day role in sudden death risk stratification Sanjeev Saksena (Warren, USA)2. Biomarkers to identify patients at risk for sudden cardiac death Werner Jung (Villingen, DE)3. Aging and sudden death risk: do we understand the relationship?Helmut Klein (Cologne, DE)4. Genetics and risk of sudden death in risk stratification models Stefan Kaab (Munich, DE) MONDAY JUNE 17, 20192:00 PM - 3:30 PMROOM SAINT JEANSession SP-12Special Session HRS-ECAS ITwo decades of arrhythmogenic cardiomyopathy (ACM) research: New insights into diagnosis and treatmentChairpersons: Richard Hauer (Utrecht, NL), Frank Marcus (Tucson, USA)Critical appraisal of the 2010 Task Force criteriaDomenico Corrado (Padua, IT) ?Use of auto-antibodies for identification of ACMFirat Duru (Zurich, CH) Role of catheter ablation in ACMHugh Calkins (Baltimore, USA)Arrhythmogenic cardiomyopathy: The Chinese experienceJiangping Song (Beijing, China) ?MONDAY JUNE 17, 20192:00 PM - 3:30 PMROOM MUCEMSession SP-13Atrial fibrillation management after pivotal clinical trials: the dilemmas Chairs: Thorsten Lewalter (Munich, DE), Luc De Roy (Louvain, BE)Should there be changes in the practice guidelines beyond the existing recommendations John Camm (London, GB) Should all patients with atrial fibrillation and systolic ventricular dysfunction be considered for catheter ablation as first line therapy Ernst Vester (Dusseldorf, DE)Patients with highly symptomatic palpitations regardless of age should be offered AF ablation as first line optionPrapa Kanagaratnam (London, GB) All catheter ablation procedures in AF are created equal as long as they include pulmonary vein isolation Andrea Natale ( Austin, USA) MONDAY JUNE 17, 20192:00 PM - 3:30 PMROOM NOTRE DAMESession SP-14Revisiting cardiac pacing in 2019: New insights into pathophysiology will lead to improved pacing therapies Supported by an educational grant from Bayer AGChairs: Jeanne Poole (Seattle, USA ), Luca Santini (Rome, IT)His Bundle pacing : what the past and present teach us about its physiologic effects Robert J. Myerburg (Miami, USA) TBC2. The clinical role of His Bundle pacing in heart failure with intraventricular conduction defects Pugazhendhi Vijayaraman (Wilkes Barre, USA) Fibrillation prevention and therapy algorithms: Do they belong in all bradycardia and tachycardia devices? TBAIs it time for mechanical physiologic benefits of multisite pacing modes to be tested in upstream therapy for heart failure and arrhythmia prevention? Sanjeev Saksena (Warren, USA)MONDAY JUNE 17, 20192:00 PM - 3:30 PMROOM LACYDONChaired Poster session D3:30 PM - 4:00 PM Coffee break and visit to postersMONDAY JUNE 17, 2019 4:00 PM - 5:30 PMROOM GRAND LARGESession SD-04Management of inherited potentially lethal arrhythmia syndromesChairpersons: Xavier Jouven (Paris, FR), Stefan Kaab (Munich, DE)Long QT syndromePeter Schwartz (Milan, IT)Brugada SyndromeXavier Jouven (Paris, FR)Catecholaminergic polymorphic ventricular tachycardiaMichael Eldar (Tel Aviv, IL)Early repolarisation syndrome Stefan Kaab (Munich, DE)MONDAY JUNE 17, 20194:00 PM - 5:30 PMROOM ESTAQUESession AF-05Atrial fibrillation meets neurologyChairpersons: Heidi Estner (Munich, DE), Soeren Z. Diederichsen, (Copenhagen, DK) Secondary stroke prevention in embolic stroke of undetermined source?(ESUS)– always go for an implanted loop recorder?Tamas Szili-Torok (Rotterdam, NL)Patent foramen ovale – always go for occlusion?Meier Bernhard (Bern, CH) LAA occluder – always close the ear?Luigi Di Biase (New-York, USA)Atrial High Rate Episodes (AHRE) – always go for anticoagulation?Michael N?bauer (Munich, DE) MONDAY JUNE 17, 20194:00 PM - 5:30 PM ROOM JOLIETTESession SP-16Special Session HRS-ECAS IIThe physician’s dilemma: Accurate prediction of sudden death in arrhythmogenic cardiomyopathy (ACM)Chairpersons: Hugh Calkins (Baltimore, USA), Richard Hauer (Utrecht, NL)Use of advanced imaging techniques in arrhythmic risk stratification of ACMAnneline te Riele (Utrecht, NL)Towards personalized risk assessment in ACMCindy James (Baltimore, USA) ?Debate: Can ACM lead to sudden death in a structurally normal heart?Protagonist : Mario Delmar (New York, USA) Antagonist: Cristina Basso (Padua, IT) ?MONDAY JUNE 17, 20194:00 PM - 5:30 PMROOM SAINT JEANSession SP-17Personalized medicine and AF: will it ever happens?Supported by an educational grant from Bayer AGChairpersons: Leonardo Calò (Rome, IT), Mark Estes III (Pittsburg, USA)In the context of 2 decades of progress do we need a new AF classification?Samuel Levy (Marseille, FR) AF MechanismsDobromir Dobrev (Essen, DE)Rhythm controlAndrea Natale (Austin, USA)Stroke preventionRiccardo Cappato (Milan, IT)MONDAY JUNE 17, 20194:00 PM - 5:30 PMROOM MUCEMSession WS-08ECG interpretation course (Part 2): Complex arrhythmias (Case-studies)A tribute to Ralph Lazzara In MemoriamIntroduction: Warren Jackman (Oklahoma City, USA) (5min)Chairpersons: John Camm (London, GB), Jean-Jacques Blanc (Brest, FR)Differential diagnosis of narrow QRS complex tachycardiasWarren Jackman (Oklahoma City, USA)Differential diagnosis of wide QRS complex tachycardiasRobert Frank (Paris, FR)TBC3. Tachycardias in the preexcitation syndromesLeonardo Calo (Rome, IT) MONDAY JUNE 17, 2019 5:30 PM - 6:15 PMROOM GRAND LARGEDebate 1First PV Isolation should be performed with a cryoballoonChairpersons: Edward Rowland (London, GB), Ellen Hoffmann (Munich, DE)Protagonist: Karl-Heinz Kuck (Hamburg, DE)Antagonist: Dipen Shah (Geneva, CH)MONDAY JUNE 17, 20195:30 PM - 6:15 PMROOM JOLIETTEDebate 2Non-pharmacologic therapy has no role in heart failure with preserved ejection fraction Chairs: John A. Camm (London, GB), Habib Haouala (Tunis, TN) Protagonist: Christian Torp-Pedersen (Copenhagen, DK) Antagonist: Sanjeev Saksena (Warren, USA)MONDAY JUNE 17, 20195:30 PM - 6:15 PMROOM MUCEMDebate 3 Sudden death prophylaxis in nonischemic cardiomyopathy: The role of implantable defibrillators should be removed from the guidelines Chairs: Niraj Varma (Cleveland, USA), Helmut Klein (Munich, DE) Protagonist: Jean-Jacques Blanc (Brest, France) Antagonist: Bruce Wilkoff (Cleveland, USA)MONDAY JUNE 17, 20195:30 PM - 6:15 PMROOM DEBARCADAIRE GRAND LARGE ?? ou SAINT JEAN ???Debate 4PVI should be 1st line therapy in all symptomatic AF patientsChairpersons: Riccardo Cappato (Milan, IT), Gilles Lascault (Paris, FR) Protagonist: Walid Saliba (Cleveland, USA)Antagonist: Mark Estes III (Pittsburg, USA)MONDAY JUNE 17, 20196:15PM-7:00PM ROOM ??Special Lecture: Mark Josephson, MD In MemoriamTUESDAY JUNE 18, 201910:30 AM - 12:00 PM ROOM GRAND LARGESession SP-19Pacing management of bradyarrhythmias - Beyond the Guidelines Chairpersons: David G Benditt (Minneapolis, USA), Luca Santini (Rome, IT)1. Can carotid sinus hypersensitivity ever be an indication for pacing?Steve Parry (Newcastle, GB) 2. Mobitz type 1 block in the elderly: A possible pacing Indication?Richard Sutton (Monaco, MC) 3. When is pacing appropriate in vasovagal syncope? Brian Olshansky (Iowa City, USA) 4. Leadless cardiac pacemakers for bradyarrhythmias Werner Jung (Villingen, DE)TUESDAY JUNE 18, 201910:30 AM - 12:00 PMROOM ESTAQUESession SP-20New tools and mapping for ablationChairpersons: Daniel Steven (Cologne, DE), Shlomo Ben-Haim (London-GB)TBCHigh-Power Short-duration for AF ablation Roger Winkle (Palo Alto, USA) Dipole density mapping (ACUTUS?) in persistent AF Tom Wong (London GB)Real-time Local Impedance Measurement Reza Wakili (Essen, DE)4. Real-time wide band di-electric sensing system (KODEX-EPD?) Evgeny Pokushalov (Novosibirsk, RU)TBCTUESDAY JUNE 18, 201910:30 AM - 12:00 PMROOM JOLIETTESession SP-21Mapping and ablation of scar related VTChairs: David Wilber (Chicago, USA), Eugene Crystal (Toronto, CA)TBCHigh- density Mapping improves outcomes of VT ablationMohammad Shenasa (San José, USA)Substrate imaging is mandatory in scar related VT ablationElena Ene (Bad Neustadt, DE)Substrate homogenization: All you can reachJose Merino (Madrid, ES)Are the guidelines on VT ablation still adequate?John Camm (London, GB) TUESDAY JUNE 18, 201910:30 AM - 12:00 PMROOM SAINT JEANSession SP-22Non-Pharmacological management of heart failure: What is new?Chairpersons: Nicholas Peters (London, GB), Erik Bloch-Thomsen (Copenhagen, DK)1. What’s new in patient selection for heart failure devices? TBA2. What’s new in LV electrodes and their placement ? Francesco Zanon (Rovigo, IT)What’s new in heart failure device programming to optimize function, at implant, post implant and beat-to-beat?Robert Hauser (Minneapolis, USA)Cardiac contractility modulation (CCM) therapy:? Does it work? How does it work??? Where does it fit with other heart failure device management?Neil Sulke (Eastbourne, GB)TUESDAY JUNE 18, 201910:30 AM - 12:00 PMROOM MUCEMSession SP-23Atrial fibrillation: emerging risk factorsChairs: Alessandro Capucci (Ancona, IT), Luis Molina (Mexico City, MX)ObesityPromound Obel (Johannesburg, ZA)Obstructive sleep apnea syndromeAdam S Fein (Boston, USA)TBCPhysical activityFrancesco Furlanello (Milan, IT)Food and antioxidationLeonardo Calò (Rome, IT)12:00 PM - 12:30 PM BEST POSTER AWARDS ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download